New drug from Gensight Biologics hits pipeline
Bernard Gilly, PhD
Advertisement
CEO, Gensight Biologics
Articles by Bernard Gilly, PhD
Advertisement
Latest Updated Articles
Pipeline: New therapies to come for debilitating eye diseasesPublished: November 12th 2020 | Updated:
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Neurotrophic keratitis in focus: Diagnosis, treatment, and practice pearls
2
The Vision Council submits formal comments to US Department of Commerce on national security investigations
3
Sydnexis releases phase 3 STAR trial results on SYD-101 0.01% for slowing myopia progression
4
Retinal diseases in the crosshairs of optometrists at Academy 2025
5
.png "Optometry Times"){kind=logo}
